CAS 122168-40-5

Ácido (3β,4α,16β,21β,22α)-28-(acetiloxi)-16,22,23-triidroxi-21-[[(2E)-2-metil-1-oxo-2-buten-1-il]oxi]olean-12-en-3-il β-D-glucopiranosidurônico

Descrição:

A substância química com o nome "Ácido (3β,4α,16β,21β,22α)-28-(acetiloxi)-16,22,23-triidroxi-21-[[(2E)-2-metil-1-oxo-2-buten-1-il]oxi]olean-12-en-3-il β-D-glucopiranosidurônico" e número CAS "122168-40-5" é um glicósido triterpenoide do tipo oleanano complexo. Apresenta múltiplos grupos hidroxila, que contribuem para sua solubilidade e reatividade, e um grupo acetyloxi que pode influenciar sua atividade biológica e estabilidade. A presença de um moiety de ácido glucopiranosidurônico indica que possui propriedades glicósidicas, potencialmente afetando sua interação com sistemas biológicos. Este composto provavelmente exibirá várias atividades farmacológicas, uma vez que muitos triterpenoides são conhecidos por suas propriedades anti-inflamatórias, antioxidantes e anticancerígenas. Sua complexidade estrutural sugere que pode participar de várias vias bioquímicas, tornando-o de interesse na química medicinal e na pesquisa de produtos naturais. A estereoquímica específica e os grupos funcionais presentes nesta molécula desempenham um papel crucial na determinação de seus efeitos biológicos e potenciais aplicações terapêuticas.

Fórmula: C₄₃H₆₆O₁₄

InChI: InChI=1S/C43H66O14/c1-10-21(2)36(53)57-34-33(50)43(20-54-22(3)45)24(17-38(34,4)5)23-11-12-26-39(6)15-14-28(55-37-31(49)29(47)30(48)32(56-37)35(51)52)40(7,19-44)25(39)13-16-41(26,8)42(23,9)18-27(43)46/h10-11,24-34,37,44,46-50H,12-20H2,1-9H3,(H,51,52)/b21-10+/t24-,25+,26+,27-,28-,29-,30-,31+,32-,33-,34-,37+,39-,40-,41+,42+,43-/m0/s1

Chave InChI: InChIKey=VEFSVJGWJQPWFS-ZXKKMYOJSA-N

SMILES: C(OC(C)=O)[C@]12[C@](C=3[C@@](C)(C[C@@H]1O)[C@@]4(C)[C@](CC3)([C@]5(C)[C@@](CC4)([C@@](CO)(C)[C@@H](O[C@@H]6O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]6O)CC5)[H])[H])(CC(C)(C)[C@@H](OC(/C(=C/C)/C)=O)[C@@H]2O)[H]

Sinónimos:

• (3beta,16beta,21beta,22alpha)-28-Acetoxy-16,22,23-trihydroxy-21-{[(2E)-2-methylbut-2-enoyl]oxy}olean-12-en-3-yl beta-D-glucopyranosiduronic acid
• (3β,4α,16β,21β,22α)-28-(Acetyloxy)-16,22,23-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl β-<span class="text-smallcaps">D</span>-glucopyranosiduronic acid
• 2-butenoic acid, 2-methyl-, (3beta,16beta,21beta,22alpha)-28-(acetyloxy)-3-(beta-D-glucopyranuronosyloxy)-16,22,23-trihydroxyolean-12-en-21-yl ester, (2E)-
• gymnemic acid I
• β-<span class="text-smallcaps">D</span>-Glucopyranosiduronic acid, (3β,4α,16β,21β,22α)-28-(acetyloxy)-16,22,23-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl
• β-<span class="text-smallcaps">D</span>-Glucopyranosiduronic acid, (3β,4α,16β,21β,22α)-28-(acetyloxy)-16,22,23-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-butenyl]oxy]olean-12-en-3-yl
• β-<span class="text-smallcaps">D</span>-Glucopyranosiduronic acid, [3β,4α,16β,21β(E),22α]-28-(acetyloxy)-16,22,23-trihydroxy-21-[(2-methyl-1-oxo-2-butenyl)oxy]olean-12-en-3-yl
• β-D-Glucopyranosiduronic acid, (3β,4α,16β,21β,22α)-28-(acetyloxy)-16,22,23-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl
• (3β,4α,16β,21β,22α)-28-(Acetyloxy)-16,22,23-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl β-D-glucopyranosiduronic acid
• β-D-Glucopyranosiduronic acid, (3β,4α,16β,21β,22α)-28-(acetyloxy)-16,22,23-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-butenyl]oxy]olean-12-en-3-yl
• β-D-Glucopyranosiduronic acid, [3β,4α,16β,21β(E),22α]-28-(acetyloxy)-16,22,23-trihydroxy-21-[(2-methyl-1-oxo-2-butenyl)oxy]olean-12-en-3-yl

Gymnemic acid I

CAS: 122168-40-5

Gymnemic acid I (Gymnemic acid I, (+)-) inhibits protein biosynthesis with antisweet principles.

Fórmula: C₄₃H₆₆O₁₄

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 806.98

Ref: TM-TN1718

Gymnemic acid I

CAS: 122168-40-5

Fórmula: C₄₃H₆₆O₁₄

Pureza: 95%~99%

Cor e Forma: Powder

Peso molecular: 806.987

Ref: BP-BP1601

Gymnemic Acid I

CAS: 122168-40-5

Fórmula: C₄₃H₆₆O₁₄

Peso molecular: 806.99

Ref: 4Z-G-226001

(+)-Gymnemic Acid I

CAS: 122168-40-5

Gymnemic acid I is a saponin that interacts with the pharmacokinetic properties of drugs and has been shown to have a potent inhibitory effect on the activity of the enzyme tiglic acid. Gymnemic acid I has been shown to be effective in the treatment of diabetic patients. The compound also has a protective effect against metabolic disorders, such as hyperglycemia and hyperlipidemia, which may be due to its ability to suppress autophagy.

Fórmula: C₄₃H₆₆O₁₄

Pureza: Min. 95%

Peso molecular: 806.98 g/mol

Ref: 3D-XEA16840